Speakers
Ahmad Nabhan
Postdoctoral Scholar
Genentech
Day 2
Thursday | April 29, 2021
10:00 am | Comparing & Contrasting Human & Murine Lungs at Single Cell Resolution
Christina Wenglen
Head of Research
AnaMar
Day 1
Wednesday | April 28, 2021
12:00 pm | Evaluating Importance of Serotonin System in Relation to Systemic Sclerosis, Fibrosis & ILDs
Craig Conoscenti
Medical Expert ILD Respiratory Clinical Development & Medical Affairs
Boehringer Ingelheim
Day 1
Wednesday | April 28, 2021
8:30 am | eep Diving in to the Progressive Phenotype of Fibrosing Interstitial Lung Disease
Dinesh Khanna
Professor
University of Michigan
Day 1
Wednesday | April 28, 2021
2:00 pm | Exploring Scleroderma Through the Lens of ILD Clinical Trials: Reviewing Success’, Challenges & Lessons Learned
Gisli Jenkins
Professor
University of Nottingham
Day 1
Wednesday | April 28, 2021
9:30 am | Exploring the Role of TGFbeta in Pulmonary Fibrosis to Evaluate Whether itsIt’s Impact is Healing or Devastating Across Various ILD Phenotypes
Jonathan Chung
Professor of Radiology
The University of Chicago Medicine
Day 2
Thursday | April 29, 2021
2:30 pm | Examining Interstitial lung disease (ILD) assessment on HRCT: Pearls & Pitfalls
Karen Moor
Pulmonologist in Training & Postdoctoral Researcher
Erasmus University
Kevin Brown
Professor &Chair, Department of Medicine
National Jewish Health
Day 1
Wednesday | April 28, 2021
9:00 am | Reviewing Recent Research on Diagnostic Accuracy, Disease Behaviour, & Response Measures
Klaus-Uwe Kirchgässler
Senior Group Global Medical Director
Roche
Day 1
Wednesday | April 28, 2021
3:30 pm | Reviewing Combination Regimes for ILD Treatment: Past, Present, Futur
Mark Hamblin
Assistant Professor, Pulmonary & Critical Care Medicine
University of Kansas Hospital
Marlies Wijsenbeek
Head of the ILD Center
Erasmus University
Day 2
Thursday | April 29, 2021
1:30 pm | Panel Discussion: Benchmarking Experiences of Integrating Home Spirometry in Clinical Trials to Determine Whether Suitable to Use in Your Next Trial
Maximiliano Tamae Kakazu
Assistant Professor of Medicine
Michigan State
Meghan Clements
Principal Research Scientist
AbbVie
Day 2
Thursday | April 29, 2021
9:30 am | nvestigating Next Generation in vivo models: Spotlight on Scleroderma
Mick Foley
La Trobe University & Chief Scientific Officer
AdAlta
Day 1
Wednesday | April 28, 2021
11:30 am | CXCR4/CXCL12: A Common Molecular Axis in Multiple Cell Types with Relevance in ILD
Monica Bengus
Senior Global Medical Director
Roche
Preethi Vijayaraj
Principal Scientist – Drug Concept Discovery, Immunology & Respiratory
Boehringer Ingelheim
Day 2
Thursday | April 29, 2021
9:00 am | Exploring in vitro Systems for Progressive Fibrotic Diseases: Spotlight on Stem Cell Based Models for the Lung
Rohit Batta
Chief Scientific Officer
Vicore Pharma
Toby Maher
Director, Interstitial Lung Disease Program
USC
Day 1
Wednesday | April 28, 2021
1:30 pm | Analyzing Lessons Learned from IPF Clinical Trials to Streamline the Design & Execution of Efficient Clinical Trials for Novel ILD Medicines
Day 2
Thursday | April 29, 2021
1:30 pm | Panel Discussion: Benchmarking Experiences of Integrating Home Spirometry in Clinical Trials to Determine Whether Suitable to Use in Your Next Trial
Joel Matthews
Director Biomarker Assay Research and Assay Development
Ionis
Majd Mouded
Executive Director for BioMedical Research
Novartis
Greg Cosgrove
Vice President Clinical Development
Pliant Therapeutics
Day 1
Wednesday | April 28, 2021
10:00 am | Integrin-Mediated TGF-β Activation: A Crucial Role in Fibrosis
Ling-Pei Ho
Associate Professor Respiratory Immunology
University of Oxford
Day 1
Wednesday | April 28, 2021
11:15 am | Role of monocytes in Pathogenesis of IPF
Emily Fraser
Consultant - Respiratory Medicine
NHS
Iris Alroy
Vice President- R&D
Anima Biotech
Day 1
Wednesday | April 28, 2021